EP3439689
AÐFERÐIR Í MEÐFERÐ VIÐ BLÓÐFITUHÆKKUN MEÐ ANGPTL8-HEMLI OG ANGPTL3-HEMLI
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.4.2017EP published:
13.10.2021EP application number:
17719107.9
EP translation filed:
3.11.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
6.4.2037Expiry date:
6.4.2023
Title:
METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR
Timeline
Today
7.4.2017EP application
13.10.2021EP Publication
3.11.2021Translation submitted
15.1.2022Registration published
6.4.2023Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
GROMADA, JesperAddress:
Tarrytown, New York 10591, US
Name:
GUSAROVA, ViktoriaAddress:
Tarrytown, New York 10591, US
Name:
MURPHY, Andrew J.Address:
Tarrytown, New York 10591, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201662319980 PDate:
8.4.2016Country:
US
Number:
201762453110 PDate:
1.2.2017Country:
US
Classification
Categories:
A61K 39/00, A61P 3/06, C07K 16/22
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 22.3.2022
Expires: 6.4.2023
Payer: Patice ehf.